期刊文献+

不同剂量氯吡格雷对急性冠脉综合征患者的氯吡格雷抵抗及超敏C反应蛋白、P选择素水平的影响 被引量:28

Effects of different doses of clopidogrel on clopidogrel resistance and hs-CRP,P-selectin levels in patients with acute coronary syndrome
下载PDF
导出
摘要 目的评价给予不同剂量氯吡格雷的急性冠脉综合征(ACS)患者氯吡格雷抵抗(CR)发生情况及对血小板聚集率和血清相关炎症因子水平的影响。方法选择ACS患者128例,随机分为两组,A组于确诊后即刻给予负荷量氯吡格雷300 mg,后服用维持量75 mg/d,B组于确诊后即刻给予负荷量600 mg,后服用维持量150 mg/d。分别于服药前和服药后3 d采用比浊法测定二磷酸腺苷(ADP)诱导的血小板聚集率;并于介入手术前、术后24 h和术后3 d分别抽取外周血,酶联免疫吸附法测定超敏C反应蛋白(hs-CRP)和P选择素水平。结果①B组的CR发生率低于A组(P<0.05)。②两组中发生CR者血小板抑制率均低于氯吡格雷反应正常者,而B组在氯吡格雷反应正常及发生CR的情况下血小板抑制率均高于A组(P<0.05)。③两组中发生CR者术后24 h及术后3 d血清hs-CRP和P选择素水平均高于药物反应正常者,而B组在药物反应正常及发生CR的情况下均较A组更有效降低血清hs-CRP、P-选择素水平(P<0.05)。结论对于ACS患者,相对于负荷量300 mg+维持量75 mg/d,给予负荷量600 mg+维持量150 mg/d的氯吡格雷可减少CR的发生率,并更有效地抑制血小板聚集及降低血清相关炎症因子水平。 Objective To evaluate the incidence of patients with acute coronary syndrome(ACS) in different doses of clopidogrel resistance(CR),and to investigate the effects of clopidogrel on platelet aggregation and the level of serum inflammatory factors.Methods 128 ACS patients were randomly divided into two groups.Group A was treated with a loading dose of 300 mg clopidogrel followed by a maintenance dose of 75 mg / d,and group B was received a loading dose of 600 mg clopidogrel followed by a maintenance dose of 150 mg / d which assigned into group A and group B respectively.The turbidimetric method was used to detect the adenosine diphosphate(ADP) induced platelet aggregation rate before treatment and 3 days after treatment respectively.The levels of high sensitivity C-reactive protein(hs-CRP) and P-selectin were determined by enzyme-linked immunosorbent assay(ELISA).Blood sampled were extracted before and 24 h and 3 days after pevcutaneous coronary intervention(PCI).Results ① The occurrence rate of CR was lower in group B than that in group A(P〈0.05).② The rate of platelet aggregation inhibition in CR was lower than that in normal drug response individuals of both groups.But the platelet aggregation inhibition rate in the occurrence of normal drug response and CR in group B was higher than that in group A(P〈0.05).③ The levels of serum hs-CRP and P-selectin of CR were higher than normal drug response individuals at 24 h and 3 days after PCI in both groups.But compared with group A,the occurrence of normal drug response and CR,the levels of serum hs-CRP and P-selectin were significantly decreased in group B(P〈0.05).Conclusion The incidence of CR and platelet aggregation and the level of serum inflammatory factors can reduce more effectively in the patients with ACS who are treated with dose of 600 mg clopidogrel followed by a maintenance dose of 150 mg / d than with 300 mg clopidogrel followed by a maintenance dose of 75 mg / d.
作者 李磊 褚俊
出处 《安徽医科大学学报》 CAS 北大核心 2012年第5期558-561,共4页 Acta Universitatis Medicinalis Anhui
关键词 急性冠脉综合征 氯吡格雷抵抗 炎症因子 acute coronary syndrome clopidogrel resistance inflammatory factors
  • 相关文献

参考文献10

  • 1Lau W C,Gurbel P A,Watkins P B,et al.Contribution of hepaticcytochrome P4503A4 metabolic activity to the phenomenon of clo-pidogrel resistance[J].Circulation,2004,109(2):166-71.
  • 2Nguyen T A,Diodati J G,Pharand C.Resistance to clopidogrel:a review of the evidence[J].J Am coll Cardiol,2005,45(8):1157-64.
  • 3Geisler T,Langer H,Wydymus M,et a1.Low response to clopi-dogrel is associated with cardiovaseular outcome after coronary stentimplantation[J].Eur Heart J,2006,27(20):2420-5.
  • 4Mason P J,Jacobs A K,Freedman J E.Aspirin resistance andatherothrombotic disease[J].J Am Coll Cardiol,2005,46(6):986-93.
  • 5Gurbel P.A.,Bliden K.P.,Zaman K.A.,张迎捷.氯吡格雷加依替巴肽抑制血小板反应性:氯吡格雷加依替巴肽抑制血小板反应性(CLEARPlatelets)研究结果[J].世界核心医学期刊文摘(心脏病学分册),2005,0(9):39-40. 被引量:28
  • 6Tavassoli N,Voisin S,Carrie D,et al.High maintenance dosageof clopidogrel is associated with a reduced risk of stent thrombosisin clopidogrel-resistant patients[J].Am J Cardiovasc Drugs,2010,10(1):29-35.
  • 7刘红旗,谈敏.冠心病患者血清肝素结合表皮生长因子样生长因子及超敏C反应蛋白水平的临床意义[J].安徽医科大学学报,2010,45(2):248-251. 被引量:7
  • 8Vivekananthan D P,Bhatt D L,Chew D P,et al.Effect of clopi-dogrel pretreatment on periprocedural rise in C-reactive protein af-ter percutaneous coronary intervention[J].Am J Cardiol,2004,94(3):358-60.
  • 9Cha J K,Jeong M H,Lee K M,et al.Changes in platelet P-se-lectin and in plasma C-reactive protein in acute atherosclerotic is-chemic stroke treated with a loading dose of clopidogrel[J].JThromb Thrombolysis,2002,14(2):145-50.
  • 10齐新,刘克强,王敏,尹皓烨,赵春杰,李松松.冠心病患者血小板聚集功能与炎症因子关系的研究[J].中国循环杂志,2009,24(3):178-181. 被引量:30

二级参考文献23

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2064
  • 2程筱雯,江志奎,朱华庆,肖林林,谢斌,胡若磊,胡超杰,张素梅,张玲,刘超,陈孝宇,何苇,桂淑玉,周莉,周青,汪渊.高脂血症模型兔血清肌酸激酶活性和C反应蛋白含量的动态变化[J].安徽医科大学学报,2007,42(2):147-150. 被引量:6
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2143
  • 4Hatsukami TS, Rishikawa H, Mukai S, et al. Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an in- travascular ultra-sound study. J Am Coll Cardiol,2001,37 ( 1 ) :63-69.
  • 5Davl G, Averna M, Catalano I, et al. Increased thromboxane biosynthesis in type IIa hypercholesterolemia. Circulation, 1992,85 : 1792-1798.
  • 6Minuz P, Patrignani P, Gaino S,et al. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation, 2002,106:2800-2805.
  • 7Di Minno G, Davi G, Margaglione M, et al. Abnormally high thromboxane biosynthesis in homozygous homocystinufia: evidence for platelet involvement and probucol-sensitive mechanism. J Clin Invest, 1993, 92 : 1400-1406.
  • 8Sidney SC, Allen J, Blair SN, et al. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease : 2006 Update. J Am Coll Cardiol, 2006,47 : 2130- 2139.
  • 9Braunwald E, Antman EM, Beasley JW, et al. American College of Cardiology; American Heart Association. Committee on the Management of patients With Unstable Angina. ACC/AHA 2002 guideline up- date for the management of patients with unstable angina and non-ST- segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines ( Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002,40: 1366- 1374.
  • 10Alpert JS,Thygesen K, Antman E,et al. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol,2000,36:959-969.

共引文献61

同被引文献195

引证文献28

二级引证文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部